Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LEXICON PHARMACEUTICALS, INC.
Report date December 31, 2020 · Filed January 06, 2021
Section 16 reporting ended · disclosed 2021-01-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-12-31 transaction · row 1
1 source rowRow 1 · 2020-12-31 · Other · Disposed 4,321,214 · Balance 0 F1: On December 31, 2020, Invus C.V. dissolved and transferred the shares of Class A common stock of the Issuer held by it to Invus Partners, LLC. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 31, 2020, Invus C.V. dissolved and transferred the shares of Class A common stock of the Issuer held by it to Invus Partners, LLC.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 31, 2020 Filed Jan 6, 2021 02:21 UTC | LEXICON PHARMACEUTICALS, INC. LXRX · Entity 4970 | OtherCommon Stock | 4,321,214 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-000539 · doc4.xml · nonDerivative · entry 1 Invus C.V. · CIK 0001378005 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On December 31, 2020, Invus C.V. dissolved and transferred the shares of Class A common stock of the Issuer held by it to Invus Partners, LLC. F1 · price: On December 31, 2020, Invus C.V. dissolved and transferred the shares of Class A common stock of the Issuer held by it to Invus Partners, LLC. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.